<DOC>
	<DOC>NCT00422422</DOC>
	<brief_summary>Initial study in children with epilepsy to evaluate the pharmacokinetics, safety, tolerability and preliminary efficacy of adjunctive treatment with brivaracetam, and to develop dosing adaptations for future studies.</brief_summary>
	<brief_title>Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Clinical diagnosis of epilepsy Subject having at least 1 seizure (any type) during the 3 weeks before first visit Stable dosing of 13 concomitant antiepileptic drugs Pregnant or nursing females Concomitant use of Levetiracetam Epilepsy secondary to a Progressive cerebral disease/tumor or other neurodegenerative disease History of status epilepticus Clinically significant acute or chronic illness, underlying disease or medication condition History of suicide attempt</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Brivaracetam</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Child</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Adolescents</keyword>
</DOC>